Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 1:40 pm Sale | 2025-09-30 | 13G | MaxCyte, Inc. MXCT | CADIAN CAPITAL MANAGEMENT LP | 8,227,603 7.700% | -1,116,821 (-11.95%) | Filing History |
| 2025-11-04 09:38 am Purchase | 2025-09-30 | 13G | MaxCyte, Inc. MXCT | MIRABELLA FINANCIAL SERVICES LLP | 8,200,000 7.690% | 1,600,000 (+24.24%) | Filing History |
| 2025-11-03 11:23 am Purchase | 2025-06-30 | 13G | MaxCyte, Inc. MXCT | MIRABELLA FINANCIAL SERVICES LLP | 6,600,000 6.200% | 6,600,000 (New Position) | Filing History |
| 2025-10-24 11:50 am Purchase | 2025-09-23 | 13D | MaxCyte, Inc. MXCT | RIVER GLOBAL INVESTORS LLP | 5,497,452 5.200% | 5,497,452 (New Position) | Filing History |
| 2025-02-13 6:17 pm Purchase | 2024-12-31 | 13G | MaxCyte, Inc. MXCT | CADIAN CAPITAL MANAGEMENT LP | 9,344,424 8.900% | 1,155,476 (+14.11%) | Filing History |
| 2025-02-05 5:28 pm Sale | 2024-12-31 | 13G | MaxCyte, Inc. MXCT | BlackRock Inc. BLK | 8,256,000 7.800% | -2,169,244 (-20.81%) | Filing History |
| 2024-11-13 7:14 pm Purchase | 2024-09-30 | 13G | MaxCyte, Inc. MXCT | CADIAN CAPITAL MANAGEMENT LP | 8,188,948 7.800% | 2,544,050 (+45.07%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | MaxCyte, Inc. MXCT | BlackRock Inc. BLK | 10,425,244 9.900% | 0 (Unchanged) | Filing History |
| 2024-10-31 4:23 pm Sale | 2024-09-30 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 4,192,865 4.000% | -1,556,150 (-27.07%) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | MaxCyte, Inc. MXCT | BlackRock Inc. BLK | 10,425,244 9.900% | 2,160,311 (+26.14%) | Filing History |
| 2024-03-25 4:36 pm Purchase | 2024-03-19 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,749,015 5.500% | 736,732 (+14.70%) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | Casdin Capital LLC | 0 0.000% | -9,220,000 (Position Closed) | Filing History |
| 2024-02-14 12:25 pm Purchase | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | CADIAN CAPITAL MANAGEMENT LP | 5,644,898 5.500% | 5,644,898 (New Position) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | MaxCyte, Inc. MXCT | The Vanguard Group | 5,282,108 5.090% | 5,282,108 (New Position) | Filing History |
| 2024-02-01 4:25 pm Sale | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,012,283 4.800% | -758,611 (-13.15%) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | BlackRock Inc. BLK | 8,264,933 8.000% | 531,720 (+6.88%) | Filing History |
| 2023-11-17 4:05 pm Purchase | 2023-11-08 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,770,894 5.600% | 5,770,894 (New Position) | Filing History |
| 2023-02-14 10:15 am Sale | 2023-02-14 | 13G | MaxCyte, Inc. MXCT | BAMCO INC /NY/ | 2,182,982 2.140% | -2,948,852 (-57.46%) | Filing History |
| 2023-02-13 2:08 pm Sale | 2022-12-31 | 13G | MaxCyte, Inc. MXCT | Sofinnova Crossover I SLP | 4,610,693 4.500% | -500,000 (-9.78%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | MaxCyte, Inc. MXCT | BlackRock Inc. BLK | 7,733,213 7.600% | 890,253 (+13.01%) | Filing History |